These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2387312)

  • 1. Reevaluation of the C3a active site using short synthetic C3a analogues.
    Köhl J; Casaretto M; Gier M; Karwath G; Gietz C; Bautsch W; Saunders D; Bitter-Suermann D
    Eur J Immunol; 1990 Jul; 20(7):1463-8. PubMed ID: 2387312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and biological activity of a new generation of synthetic C3a analogues by combination of peptidic and non-peptidic elements.
    Gerardy-Schahn R; Ambrosius D; Casaretto M; Grötzinger J; Saunders D; Wollmer A; Brandenburg D; Bitter-Suermann D
    Biochem J; 1988 Oct; 255(1):209-16. PubMed ID: 3264156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activities of synthetic anaphylatoxic peptides in widely used biological assays.
    Kola A; Klos A; Bautsch W; Kretzschmar T; Köhl J
    Clin Exp Immunol; 1992 May; 88(2):368-72. PubMed ID: 1572104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic peptides as antagonists of the anaphylatoxin C3a.
    Kretzschmar T; Pohl M; Casaretto M; Przewosny M; Bautsch W; Klos A; Saunders D; Köhl J
    Eur J Biochem; 1992 Nov; 210(1):185-91. PubMed ID: 1446671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the C-terminal C5a effector site with short synthetic C5a analog peptides.
    Köhl J; Lübbers B; Klos A; Bautsch W; Casaretto M
    Eur J Immunol; 1993 Mar; 23(3):646-52. PubMed ID: 8383599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of C3a receptor-proteins on guinea pig platelets and human polymorphonuclear leukocytes.
    Gerardy-Schahn R; Ambrosius D; Saunders D; Casaretto M; Mittler C; Karwarth G; Görgen S; Bitter-Suermann D
    Eur J Immunol; 1989 Jun; 19(6):1095-102. PubMed ID: 2666143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Designing synthetic superagonists of C3a anaphylatoxin.
    Ember JA; Johansen NL; Hugli TE
    Biochemistry; 1991 Apr; 30(15):3603-12. PubMed ID: 2015217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C3a induced activation and stimulus specific reversible desensitization of guinea pig platelets.
    Zanker B; Rasokat H; Hadding U; Bitter-Suermann D
    Agents Actions Suppl; 1982; 11():147-57. PubMed ID: 6983827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mechanism of action for anaphylatoxin C3a stimulation of mast cells.
    Mousli M; Hugli TE; Landry Y; Bronner C
    J Immunol; 1992 Apr; 148(8):2456-61. PubMed ID: 1373170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: alternative splicing in the large extracellular loop.
    Fukuoka Y; Ember JA; Hugli TE
    J Immunol; 1998 Sep; 161(6):2977-84. PubMed ID: 9743361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide analogues of the anaphylatoxin C3a; syntheses and properties.
    Ambrosius D; Casaretto M; Gerardy-Schahn R; Saunders D; Brandenburg D; Zahn H
    Biol Chem Hoppe Seyler; 1989 Mar; 370(3):217-27. PubMed ID: 2713103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of antimicrobial C3a analogues with enhanced effects against Staphylococci using an integrated structure and function-based approach.
    Pasupuleti M; Walse B; Svensson B; Malmsten M; Schmidtchen A
    Biochemistry; 2008 Sep; 47(35):9057-70. PubMed ID: 18690701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic C3a analogs as specific inhibitors of C3a activity.
    Meuer S; Hadding U; Andreatta R; Bitter-Suermann D
    Immunopharmacology; 1981 Sep; 3(3):275-80. PubMed ID: 6975766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of a specific C3a receptor on guinea pig platelets.
    Fukuoka Y; Hugli TE
    J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced biopotency of synthetic C3a analogues by membrane binding. A fluorescence anisotropy decay study.
    Federwisch M; Casaretto M; Gerardy-Schahn R; Bitter-Suermann D; Wollmer A
    Biophys Chem; 1992 Oct; 44(3):151-61. PubMed ID: 1420945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic disulfide analogues of the complement component C3a. Synthesis and conformational investigations.
    Pohl M; Ambrosius D; Grötzinger J; Kretzschmar T; Saunders D; Wollmer A; Brandenburg D; Bitter-Suermann D; Höcker H
    Int J Pept Protein Res; 1993 Apr; 41(4):362-75. PubMed ID: 8496018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of humoral immune responses by synthetic C3a peptides.
    Morgan EL; Weigle WO; Erickson BW; Fok KF; Hugli TE
    J Immunol; 1983 Nov; 131(5):2258-61. PubMed ID: 6355293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood- and skin-derived monocytes/macrophages respond to C3a but not to C3a(desArg) with a transient release of calcium via a pertussis toxin-sensitive signal transduction pathway.
    Zwirner J; Götze O; Moser A; Sieber A; Begemann G; Kapp A; Elsner J; Werfel T
    Eur J Immunol; 1997 Sep; 27(9):2317-22. PubMed ID: 9341775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biologic activity of synthetic analogues of C5a anaphylatoxin.
    Ember JA; Sanderson SD; Taylor SM; Kawahara M; Hugli TE
    J Immunol; 1992 May; 148(10):3165-73. PubMed ID: 1578141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.